2,4-Dimethylpyrimidine-5-carboxylic acid, 97.0%, 25g

5-Benzyloxy-1H-indole-2-carboxylic acid, 97.0%, 5g

Infinity corrected plan phase S40x/0.65 objective. Working distance 0.36 mm

(S)-1-(6-(4-METHYLTHIAZOL-5-YL)PYRIDIN-3-YL)ETHAN-1-AMINE HCL, 95%, 250mg

4-(acetylamino)-5-chloro-2-methoxybenzoic acid, 98.0%, 250mg

(S)-3-Aminotetrahydrofuran hydrochloride, 95.0%, 10g

1,2-bis-(toluene-4-sulfonylamino)-benzene, 97%, 1g

4-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide, 95.0%, 1g

Nitrilotris(methylenephosphonic acid) (ca. 50% in water, ca. 2.2mol/L), 95.0%, 100g

9-Phenyl-9H,9'H-2,3'-bicarbazole>98.0%(HPLC)(N)1g

1,4-Dihydro-4-oxoquinoline-3-carboxylic Acid>98.0%(HPLC)(T)5g

Methyl (2S,4S)-1-Boc-4-aminopyrrolidine-2-carboxylate hydrochloride, 97.0%, 100g

2'-Methyl-5'-(trifluoromethyl)acetophenone, 250mg